Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$0.58 USD
-0.04 (-6.87%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $0.59 +0.01 (0.99%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 20.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.15 |
Next Year | -0.84 |
EPS (TTM) | -0.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | -0.52M | 126.47M | 126.32M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.35 | -1.15 | -0.84 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | NA | NA | -1.28 | NA |
High Estimate | -0.27 | -0.30 | -0.80 | -0.37 |
Low Estimate | -0.43 | -0.39 | -1.57 | -1.46 |
Year ago EPS | -0.57 | 0.36 | -0.89 | -1.15 |
Year over Year Growth Est. | 36.84% | -197.22% | -29.21% | 27.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.35 | -1.15 | -0.84 |
7 Days Ago | -0.36 | -0.35 | -1.15 | -0.84 |
30 Days Ago | -0.36 | -0.35 | -1.15 | -0.84 |
60 Days Ago | -0.38 | -0.34 | -1.26 | -0.63 |
90 Days Ago | -0.38 | -0.33 | -1.25 | -0.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.35 | -1.15 | -0.84 |
Zacks Consensus Estimate | -0.36 | -0.35 | -1.15 | -0.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.37 | 0.36 | -0.57 | NA |
Estimate | -0.40 | -0.47 | 0.55 | -0.57 | NA |
Difference | 0.08 | 0.10 | -0.19 | 0.00 | 0.00 |
Surprise | 20.00% | 21.28% | -34.55% | 0.00% | 1.68% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more